CD56, also known as neural cell adhesion molecule (NCAM), is expressed in more than 70% of MM patients and plays a crucial role in the migration and adhesion of tumor cells in the bone marrow [232,233]. This evidence concerns the gene NCAM1 and Miyoshi myopathy.